Treatment of HAE

Help your patients treat hereditary angioedema (HAE)
FIRAZYR is indicated for the treatment of acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.
Share / Send / Save

From diagnosis and recognizing an attack to the clinical practice recommendations for an HAE treatment plan, these pages provide an overview of important information that can support you in caring for people who have HAE.

Diagnosis

Learn about the clinical presentation of HAE — recommended testing and the importance of early, accurate diagnosis.

Learn about diagnosing HAE »

Attack Presentation

See the signs and symptoms of HAE attacks in various parts of the body.

Review HAE attack presentation »

Unpredictability of Attacks

HAE attacks can be difficult to predict and can vary greatly from person to person in terms of triggers, frequency and severity.1,2

Learn about HAE attacks »

Evolving Treatment Paradigms

View select clinical practice recommendations for the treatment of HAE.

Read the selected guidelines »